Skip to content
Beacon

OSCXDefiance Daily Target 2x Long OSCR ETF

Take a betNewRanked #662 of 949 in this goal

Seeks daily investment results of 200% the daily percentage change in the share price of Oscar Health, Inc.

By Defiance ETFs LLC · Launched 2025

Annual Cost

1.31%

#5,611 of 5,861 · expensive

Fund Size

$9M

#4,924 of 5,861 · small

Return (1Y)Goal

N/A

Track Record

11 months

#4,674 of 5,861 · young

Performance

Total-return NAV · USD
Growth of $10,000
$15,778+57.8%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Leveraged

What it actually holds

By weight

Concentration

single-stock bet — holdings shown are derivatives collateral, not diversification

N/A
12.0%
N/A
11.7%
TREASURY BILL
11.0%
N/A
10.9%
N/A
10.8%
N/A
10.8%
First American Government Obli
1.1%

Asset allocation

Stocks
206.8%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-83.4%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
NASDAQ Global Select Market

Full fund details

Objective
Seeks daily investment results of 200% the daily percentage change in the share price of Oscar Health, Inc.
Strategy
Actively managed ETF aiming for 200% daily exposure to Oscar Health, Inc. through derivatives like swaps and options. Daily rebalancing is employed to maintain this leverage, with a focus on short-dated options for flexibility.
Inception date
September 24, 2025
Fund family
Defiance ETFs LLC

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Most of these lose money

These funds amplify one stock's daily move, then reset every day. More than half of them have lost money outright, and the daily reset plus financing costs drag roughly 9.5% a year off the return. The longer you hold, the more that compounding works against you.

Sources: Bessembinder, 'Leveraged Single-Stock ETFs' (SSRN 2025)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at OSCX. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-04